Cart

Monitored and updated daily, the Drug/Medical Device report provides the most complete and accurate coverage of a company's FDA approved products and pipeline candidates. The report includes a detailed presentation of each drug/device candidate's indication, its clinical trial status (i.e. preclinical, Phase 1, Phase 2, Phase 3, NDA/BLA Filed, IDE Filed, 510K/PMA Filed, Approvable Letter Received), and its mechanism of action. In addition, the report identifies the strategic disease focus of a company and outlines its pipeline diversification across various disease sectors and sub-sectors (i.e. Cardiology, Oncology, Neurology, Immunology, Urology, etc.). In summary, the Drug/Medical Device report makes available 3 key pieces of data that help determine the performance and risk of most Biotech, Pharmaceutical and Medical Device companies: (1) product/candidate pipeline, (2) product/candidate regulatory status, and (3) product/candidate pipeline diversification.